Innate immune responses to Proteus mirabilis flagellin in the urinary tract

Microbes and Infection

Volumn 15, Issue 10-11, 2013, Pages 688-696

  Umpiérrez, Ana ^a   Scavone, Paola ^a   Romanin, David ^b   Marqués, Juan Martín ^c   Chabalgoity, José Alejandro ^c   Rumbo, Martín ^b   Zunino, Pablo ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c Universidad de la Republica Instituto de Higiene   (Uruguay)

Author keywords

Flagellin; Innate immune response; Proteus mirabilis; UTI

Indexed keywords

CHEMOKINE; FLAGELLIN; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BLADDER EPITHELIUM; BLADDER IRRIGATION; CELL CULTURE; CELL LINE; CONTROLLED STUDY; FEMALE; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEUS MIRABILIS; URINARY TRACT; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; PROTEUS MIRABILIS;

FLAGELLIN; INNATE IMMUNE RESPONSE; PROTEUS MIRABILIS; UTI;

ANIMALS; CELL LINE; FEMALE; FLAGELLIN; HUMANS; IMMUNITY, INNATE; MICE; PROTEUS MIRABILIS; URINARY BLADDER;

EID: 84884134572     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.06.007     Document Type: Article

References (45)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Dis. Mon. 2003, 49:53-70.
2. Gonzalez C.M., Schaeffer A.J. Treatment of urinary tract infections: what's old, what's new and what works. World J. Urol. 1999, 17:372-382.
3. Nielubowicz G.R., Mobley H.L.T. Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol. 2010, 7:430-441.
4. O'Hanley P. Prospects for urinary tract infection vaccines in Mobley HLT. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management 1996, 405-425. ASM Press, Washington DC. J.W. Warren (Ed.).
5. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis. Mon. 2003, 49:71-82.
6. Rosser C.J., Bare R.L., Meredith J.W. Urinary tract infections in the critically ill patient with a urinary catheter. Am. J. Surg. 1999, 177:287-290.
7. Gales A.C., Sader H.S., Jones R.N. Urinary tract infections trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 2002, 44:289-299.
8. Mathai D., Jones R.N., Pfaller M.A. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY antimicrobial surveillance program (North America). Diagn. Microbiol. Infect. Dis. 2001, 40:129-136.
9. Duan Q., Zhou M., Zhu L., Zhu G. Flagella and bacterial pathogenicity. J. Basic Microbiol. 2012, 52:1-8.
10. Murthy K.G., Deb A., Gooneskera S., Szabo C., Salzman A.L. Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response invitro. J. Biol. Chem. 2004, 279:5667-5675.
11. Ramos H.C., Rumbo M., Sirard J.C. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12:509-517.
12. Andersen-Nissen E., Smith K.D., Strobe K.L., Barrett S.L., Cookson B.T., Logan S.M., Aderem A. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9247-9252.
13. Eaves-Pyles T.D., Wong H.R., Odoms K., Pyles R.B. Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J. Immunol. 2001, 167:7009-7016.
14. Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 2003, 4:1247-1253.
15. Manos J., Artimovich E., Belas R. Enhanced motility of Proteus mirabilis strain expressing hybrid FlaAB flagella. Microbiology 2004, 150:1291-1299.
16. Belas R., Flaherty D. Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. Gene 1994, 128:33-41.
17. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410:1099-1103.
18. Honko A.N., Mizel S.B. Mucosal administration of flagellin induces innate immunity in the mouse lung. Infect. Immun. 2004, 72:6676-6679.
19. Nempont C., Cayet D., Rumbo M., Bompard C., Villeret V., Sirard J.C. Deletion of flagellin's hypervariable region abrogates antibody-mediated neutralization and systemic activation of TLR5-dependent immunity. J. Immunol. 2008, 181:2036-2043.
20. Mizel S.B., Bates J.T. Flagellin as an adjuvant: cellular mechanisms and potential. J. Immunol. 2010, 185:5677-5682.
21. Bates J.T., Honko A.N., Graff A.H., Kock N.D., Mizel S.B. Mucosal adjuvant activity of flagellin in aged mice. Mech. Ageing Dev. 2008, 129:271-281.
22. Honko A.N., Mizel S.B. Effects of flagellin on innate and adaptive immunity. Immunol. Res. 2005, 33:83-101.
23. Honko A.N., Sriranganathan N., Lees C.J., Mizel S.B. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect. Immun. 2006, 74:1113-1120.
24. Nguyen C.T., Kim S.Y., Kim M.S., Lee S.E., Rhee J.H. Intranasal immunization with recombinant PspA fused with a flagellon enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine 2011, 29:5731-5739.
25. Piccini C.D., Barbe F.M., Legnani-Fajardo C.L. Identification of iron-regulated outer membrane proteins in uropathogenic Proteus mirabilis and its relationship with heme uptake. FEMS Microbiol. Lett. 1998, 166:243-248.
26. Zunino P., Geymonat L., Allen A.G., Legnani-Fajardo C., Maskell D.J. Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol. Med. Microbiol. 2000, 29:137-143.
27. Zunino P., Piccini C., Legnani-Fajardo Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection. Microb. Pathog. 1994, 16:379-385.
28. Allison N., O'Donnell M.J., Fewson C.A. Membrane-bound lactate dehydrogenases and mandelate dehydrogenases of Acinetobacter colcoaceticus. Purification and properties. Biochem. J. 1985, 231:407-416.
29. Didierlaurent A., Ferrero I., Otten L.A., Dubois B., Reinhardt M., Carlsen H., Blomhoff R., Akira S., Kraehenbuhl J.P., Sirard J.C. Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J. Immunol. 2004, 172:6922-6930.
30. Rumbo M., Anderle P., Didierlaurent A., Sierro F., Debard N., Sirard J.C., Finke D., Kraehenbuhl J.P. How the gut links innate and adaptive immunity. Ann. N. Y. Acad. Sci. 2004, 1029:16-21.
31. Tolson D.L., Harrison B.A., Latta R.K., Lee K.K., Altman E. The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells. Can. J. Microbiol. 1997, 43:709-717.
32. Livak K.J., Schimittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
33. Saban M.R., Saban R., Hammond T.G., Haak-Frendscho M., Steinberg H., Tengowski M.W., Bjorling D.E. LPS-sensory peptide communication in experimental cystitis. Am. J. Physiol. Ren. Physiol. 2002, 282:202-210.
34. Alamuri P., Eaton K.A., Himpsl S.D., Smith S.N., Mobley H.L.T. Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin invivo, protects against Proteus mirabilis urinary tract infection. Infect. Immun. 2009, 77:632-641.
35. Muñoz N., Van Maele L., Marques J.M., Rial A., Sirard J.C., Chabalgoity J.A. Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection. Infect. Immun. 2010, 78:4226-4233.
36. Mourglia-Ettlin G., Marqués J.M., Chabalgoity J.A., Dematteis S. Early peritoneal immune response during Echinococcus granulosus establishment displays a biphasic behavior. PLoS Negl. Trop. Dis. 2011, 5:1-11.
37. Simon R., Samuel C.E. Activation of NF-kappaB-dependent gene expression by Salmonella flagellins FliC and FljB. Biochem. Biophys. Res. Commun. 2007, 355:280-285.
38. McDermott P.F., Ciacci-Woolwine F., Snipes J.A., Mizel S.B. High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect. Immun. 2000, 68:5525-5529.
39. Manos J., Belas R. Transcription of Proteus mirabilis flaAB. Microbiology 2004, 150:2857-2863.
40. Song J., Abraham S.N. Innate and adaptive immune responses in the urinary tract. Eur. J. Clin. Invest. 2008, 38:21-28.
41. Haraoka M., Hang L., Frendeus B., Godlay G., Burdick M., Strieter R., Svanborg C. Neutrophil recruitment and resistance to urinary tract infection. J. Infect. Dis. 1999, 180:1220-1229.
42. Yu F.S., Cornicelli M.D., Kovach M.A., Newstead M.W., Zeng X., Kumar A., Gao N., Yoon S.G., Gallo R.L., Standiford T.J. Flagellinstimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J. Immunol. 2010, 185:1142-1149.
43. Errea A., Moreno G., Sisti F., Fernandez J., Rumbo M., Hozbor D.F. Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization. Med. Microbiol. Immunol. 2010, 199:103-108.
44. Jarchum I., Liu M., Lipuma L., Pamer E.G. Toll-like receptor 5 stimulation protects mice from acute Clostridium difficile colitis. Infect. Immun. 2011, 79:1498-1503.
45. Kinnebrew M.A., Ubeda C., Zenewicz L.A., Smith N., Flavell R.A., Pamer E.G. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 2010, 201:534-543.